Lista de obras - Nicole Tubiana Mathieu - Dominio Público Uruguay

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.

artículo científico publicado en 2013

A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples

artículo científico publicado en 2005

AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens

artículo científico publicado en 1997

Adjuvant treatment of colon cancer MOSAIC study's main results

artículo científico publicado en 2006

Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features

artículo científico publicado en 1995

Androgen, estrogen and progestin binding sites in human leukemic cells

scientific article published on 01 June 1981

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

artículo científico publicado en 2017

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

artículo científico publicado en 2015

Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity.

artículo científico publicado en 2009

Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer

artículo científico publicado en 2016

Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study

artículo científico publicado en 2015

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study

artículo científico publicado en 2017

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study

artículo científico publicado en 2005

Docetaxel Plus Gemcitabine in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head And Neck

artículo científico publicado en 2007

Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.

artículo científico publicado en 2004

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial

artículo científico publicado en 2015

Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients

artículo científico publicado en 2016

Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort

artículo científico publicado en 2016

Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer

artículo científico publicado en 2016

Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems

artículo científico publicado en 1986

Etoposide and cisplatinum in resistant lymphomas

artículo científico publicado en 1987

Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer

artículo científico publicado en 2016

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study

artículo científico publicado en 2005

Follow-up of endometrial cancer

artículo científico publicado en 2014

High dose chemotherapy in ovarian cancer.

artículo científico publicado en 2001

High-dose methotrexate: Methotrexate and 7-hydroxymethotrexate diffusion in cerebrospinal fluid

scientific article published on 01 July 1988

Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

artículo científico publicado en 1995

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

article

Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: two cases considered

scientific article published on 01 September 2007

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

artículo científico publicado en 2011

Long-Term Survival in Adult Neuroblastoma with Multiple Recurrences ⬇️

artículo científico publicado el 24 de febrero de 2010

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

artículo científico publicado en 2014

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study

artículo científico publicado en 2006

Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer

artículo científico publicado en 2014

Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment

artículo científico publicado en 1994

Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer

artículo científico publicado el 1 de junio de 2013

Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer.

artículo científico publicado en 2012

Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer

artículo científico publicado en 2002

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

artículo científico publicado en 2007

Phase-I?II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas

artículo científico publicado en 1985

Plasma kinetic study of folinic acid and 5-methyltetrahydrofolate in healthy volunteers and cancer patients by high-performance liquid chromatography

scientific article published on 01 January 1987

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial

artículo científico publicado en 2005

Prise en charge initiale des cancers gynecologiques : Referentiels de la Societe Francaise d'Oncologie Gynecologique (SFOG)

artículo científico publicado en 2008

Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.

artículo científico publicado en 2013

Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme)

artículo científico publicado en 2020

Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer

artículo científico publicado en 2011

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

artículo científico publicado en 1998

Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: a trial of the EORTC Early Clinical Studies Group.

artículo científico publicado en 1998

Résection vasculaire et cancers annexiels : à propos de 2 cas

artículo científico publicado en 2014

Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort

artículo científico publicado en 2015

Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.

artículo científico publicado en 2003

Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial.

artículo científico publicado en 2002

Sex steroid binding to human lymphocytes plasma membrane.

artículo científico publicado en 1984

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Adminis

artículo científico publicado en 2003

Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease ⬇️

artículo científico publicado el 1 de mayo de 1991

Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship

artículo científico publicado en 2017

Treatment of carcinoma of the uterine cervix with concomitant cisplatin, 5-fluorouracil and split course hyperfractionated radiotherapy

artículo científico publicado en 1998

Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantation

artículo científico publicado en 1986

c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse

article

Lista de obras de Nicole Tubiana Mathieu

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.

A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples

AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens

Adjuvant treatment of colon cancer MOSAIC study's main results

Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features

Androgen, estrogen and progestin binding sites in human leukemic cells

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity.

Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer

Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study

Docetaxel Plus Gemcitabine in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head And Neck

Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial

Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients

Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort

Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer

Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems

Etoposide and cisplatinum in resistant lymphomas

Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study

Follow-up of endometrial cancer

High dose chemotherapy in ovarian cancer.

High-dose methotrexate: Methotrexate and 7-hydroxymethotrexate diffusion in cerebrospinal fluid

Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: two cases considered

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

Long-Term Survival in Adult Neuroblastoma with Multiple Recurrences ⬇️

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study

Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer

Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment

Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer

Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer.

Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

Phase-I?II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas

Plasma kinetic study of folinic acid and 5-methyltetrahydrofolate in healthy volunteers and cancer patients by high-performance liquid chromatography

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial

Prise en charge initiale des cancers gynecologiques : Referentiels de la Societe Francaise d'Oncologie Gynecologique (SFOG)

Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.

Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme)

Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: a trial of the EORTC Early Clinical Studies Group.

Résection vasculaire et cancers annexiels : à propos de 2 cas

Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort

Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.

Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial.

Sex steroid binding to human lymphocytes plasma membrane.

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Adminis

Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease ⬇️

Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship

Treatment of carcinoma of the uterine cervix with concomitant cisplatin, 5-fluorouracil and split course hyperfractionated radiotherapy

Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantation

c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse